Biotech ETF Overview

No one U.S. biotech ETFs provides comprehensive, unbiased access to the space. Instead, each captures a piece of it—and of related industries like pharmaceuticals and medical. Tread carefully here, as each fund defines biotech differently, and the differences have material impacts on performance: In some years, the difference between the best-performing and the worst-performing biotech ETF exceeds 15%. The good news is that most of these biotech ETFs are relatively efficient and liquid.

Daily ETF Watch

First Trust Plans ‘SMID’ Dividend ETF

New small/midcap fund will target stocks exhibiting steady dividend growth.

Daily Hot Reads

Thursday Hot Reads: All ETF Data Not Created Equal

Also, biotech and MLP ETFs back in the limelight.

Daily Hot Reads

Monday Hot Reads: Where To Invest $10K Right Now

Also, biotech ETF cruises to 18-month high.

Daily Hot Reads

Friday Hot Reads: Why Bogle Doesn’t Fly First Class

Also, biotech stocks break out.

Features and News

15 Most Shorted ETFs

Investors are betting heavily against these exchange-traded funds.

Features and News

2 Key Drivers Behind Biotech ETF Rally

The segment is delivering some impressive gains after a bout of investor doubt.

Weekly ETF Flows

Int'l Equity & Biotech ETFs Fuel Weekly Inflows

U.S.-listed ETFs took in $3.6 billion in new money in the latest week.

Daily Hot Reads

Friday Hot Reads: Biotech ETFs Heating Up

What biotech ETFs to consider now, and a look at the resilience of dividend ETF investors.

Weekly ETF Flows

Weekly Inflows Slow To A Trickle

Inflows into U.S.-listed ETFs were positive, but they fell significantly from the lofty levels of the past few weeks.